Insider Transactions in Q1 2023 at Lucira Health, Inc. (LHDX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2023
|
Kevin Walter Collins Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
81,717
-25.81%
|
$0
$0.48 P/Share
|
|
Mar 07
2023
|
Richard Clavano Narido Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,382
-2.97%
|
$0
$0.45 P/Share
|
|
Mar 06
2023
|
Richard Clavano Narido Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,910
-2.32%
|
$0
$0.57 P/Share
|
|
Mar 03
2023
|
Erik T. Engelson President and Chief Executive |
SELL
Open market or private sale
|
Direct |
634,666
-79.69%
|
$634,666
$1.06 P/Share
|
|
Mar 03
2023
|
Erik T. Engelson President and Chief Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
574,666
+46.62%
|
$0
$0.82 P/Share
|
|
Mar 03
2023
|
Kevin Walter Collins Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
30,102
-8.68%
|
$30,102
$1.15 P/Share
|
|
Mar 03
2023
|
Richard Clavano Narido Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,091
-8.47%
|
$25,091
$1.07 P/Share
|
|
Mar 03
2023
|
Anthony Joseph Allen Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
8,405
-5.8%
|
$8,405
$1.0 P/Share
|
|
Feb 16
2023
|
Ghazi Kashmolah Ex VP & Chief Quality Officer |
SELL
Open market or private sale
|
Direct |
5,028
-3.61%
|
$0
$0.27 P/Share
|